- Vitamin D
- Sunshine vitamin
For Patients & Caregivers
Adequate vitamin D intake is needed for bone health and other important biologic functions. There are links between increased vitamin D intake and reduced risk of breast and colorectal cancers, but protection against other cancers remains unclear.
Vitamin D is an essential vitamin that is found in certain foods such as fortified milk and cereals, egg yolks, and fish. It is also produced in skin that is exposed to sunlight. Its primary function is to maintain adequate blood calcium and phosphorus levels by increasing absorption of these minerals from the diet through the small intestine. When dietary calcium intake is too low, vitamin D helps move calcium stores from the bones into the blood.
Vitamin D is also involved in many other biologic functions such as immune and hormone regulation, and has anti-cancer properties. Intake of vitamin D through diet may protect against breast or colorectal cancers or improve markers of prostate cancer. However, effects against other cancers remain unclear.
The Institute of Medicine recommends a higher Dietary Allowance of vitamin D at 600 IU/day with the Upper level Intake at 4,000 IU/day for bone health. Scientists know that it is helpful to take vitamin D supplements when patients are deficient in this vitamin, and certain populations including cancer patients can be especially prone to this deficiency. However, there is some debate about what level of supplementation is appropriate. Patients should consult with their physicians if more vitamin D is needed for health maintenance or to treat deficiency.
- To prevent or treat cancer
Intake of vitamin D through diet may protect against breast or colorectal cancers or affect markers for prostate cancer. However, vitamin D by itself does not prevent or treat cancer. Other large studies show that high vitamin D levels do not reduce the risk of many other cancers, and may increase risk for pancreatic or aggressive prostate cancer. More studies are needed to evaluate vitamin D in different populations.
- For immune regulation
Vitamin D contributes to hormone regulation and other processes involving immune function. In addition, a deficiency in this vitamin can be prevalent in certain populations, including those with cancer or autoimmune disorders. However, studies on effects of vitamin D supplementation on immune regulation are lacking.
- To prevent osteoporosis
Several clinical trials and population studies show that adequate levels of vitamin D intake are needed to prevent osteoporosis and bone fractures. In postmenopausal women and elderly populations, vitamin D supplementation may improve bone mineral density and help to prevent fractures.
- To prevent multiple sclerosis (MS)
A recent study involving a large number of women suggests that correcting vitamin D deficiency may reduce future risk of MS.
- To treat seasonal affective disorder (SAD)
Vitamin D supplementation does not appear to improve SAD.
- You take aluminum hydroxide: Vitamin D supplementation may increase the absorption and blood level of aluminum.
- You take atorvastatin: Vitamin D reduces blood levels of atorvastatin, but it also helps to lower cholesterol concentrations.
- You take thiazide diuretics: Vitamin D supplementation may increase serum calcium levels.
- Although rare, too much vitamin D can cause abnormally high levels of calcium in the blood or urine, or kidney stones.
- Patients with kidney stones, kidney disease, high blood calcium levels, gastrointestinal disease, heart disease, liver disease or other diseases associated with disorders of calcium metabolism should seek medical advice before taking supplemental vitamin D.
For Healthcare Professionals
Vitamin D refers to several forms of fat-soluble vitamins found in fortified milk and cereals, egg yolks, and fish. The two forms utilized in humans are ergocalciferol (D2) and cholecalciferol (D3). Sunlight can promote the synthesis of D3 in the skin. Vitamin D maintains serum calcium and phosphorus levels by regulating their absorption and excretion, and is important for bone formation. Other biologic functions include its role as an antiproliferative agent (1), and as a pro-differentiation hormone (2) with anti-inflammatory and immunoregulatory properties (3). Low levels of vitamin D are associated with a greater risk of mortality (13), may affect cardiovascular health (14), and increase the risk for development of multiple sclerosis in women (74), but a large study found no association between lower levels and cognitive function (15). However, deficiency during pregnancy may affect the neuro-cognitive development of newborns (75). Deficiency can also cause rickets or other bone disorders, and may be a risk factor for extra-skeletal diseases (45). Furthermore, deficiencies can be particularly prevalent with certain demographics including time of the year or living in northern climates (9); in non-Caucasian race (46) or obese individuals (47); with chronic use of steroids or anticonvulsants; or with diseases such as autoimmune disorders (3), cystic fibrosis (48), kidney disease, and cancer (46) (48) (49).
Clinical data show that vitamin D improves bone mineral density and fracture prevention in the elderly (4) (5) and in postmenopausal women (6). But data are conflicting for primary fracture prevention in men or women following vitamin D and calcium supplementation (7) (8) (9). In another study, high-dose vitamin D had no benefit on lower extremity function, and was associated with increased risk of falls (64).
Findings from studies evaluating its effect on cardiovascular (CV) risk factors have varied across populations and regimens: In a Women’s Health Initiative sub-study, calcium+vitamin D and hormone therapy had a greater effect than either intervention alone or placebo (67); but daily vitamin D did not appear to improve CV risk factors or physical function in a large long-term trial of older adults (68). Yet in another placebo-controlled trial, vitamin D supplementation benefited diabetic patients with coronary artery disease who were vitamin D-deficient (69). In addition, a single large dose of vitamin D2 improved endothelial function in type-2 diabetic patients (11). In non-dialysis patients with chronic kidney disease, D3 was more effective than D2 in raising serum D levels (70). Dietary vitamin D intake was also shown to be inversely associated with mortality from stroke (76).
In other trials, supplementation was found ineffective in reducing the incidence or severity of upper respiratory tract infections (URTIs) in healthy adults (16) or in preventing viral upper respiratory tract infections in children (71). It also did not reduce infections or antibiotic use in an elderly population (17), or improve seasonal affective disorder (SAD) (18) (19). But supplementation may reduce relapse risk in patients with Crohn’s disease (12), and D3+calcium can help prevent weight gain in postmenopausal women (10). In addition, a single oral high-dose of D3 significantly improved fatigue in healthy persons who were vitamin D-deficient (72).
Vitamin D has also been examined for its benefits as a preventive agent and as a treatment for many types of cancer. In animal models, dietary vitamin D3 demonstrated chemopreventive effects against breast cancer equivalent to those elicited by calcitriol without causing hypercalcemia (20). In humans, vitamin D from sunlight exposure and dietary intake may have protective effects against breast cancer (21) (22), and correlates with observations in many breast cancer survivors who were vitamin D-deficient (23). In postmenopausal women who do not use estrogen therapy, vitamin D and calcium supplementation may reduce the incidence of colorectal cancer (24) (25); and in women with grade 1 cervical intraepithelial neoplasia, long-term supplementation resulted in regression and in improved metabolic status (66). However, in a large trial of healthy postmenopausal women with mean vitamin D levels above those of the US population, taking vitamin D3+calcium did not lower cancer risk after 4 years of supplementation (73). In patients with advanced hormone-refractory prostate cancer, vitamin D improved pain and muscle strength (26), and slowed the rate of rise of prostate specific antigen (13). In older patients with diffuse large B-cell lymphoma, supplementation normalized vitamin D levels and enhanced efficacy of rituximab (27). Active vitamin D compounds may also decrease the incidence of post-transplant malignancy among kidney transplant recipients (28).
Other data reveal that vitamin D deficiency was highly prevalent in advanced pancreatic cancer (42) and colorectal cancer patients (43). And increased vitamin D intake reduced the risk of colorectal cancer (29) (30) (31) (32) (33), but had no effect on colorectal adenomas (65). High circulating vitamin D levels may also not reduce the risk of non-Hodgkin lymphoma (34), ovarian (35), kidney (36), endometrial (37), skin (38), or esophageal and gastric (39) cancers, and may significantly increase risk of pancreatic (40) or aggressive prostate cancer (41). Meta-analyses evaluating vitamin D supplementation for cancer prevention in adults indicate that although it decreases cancer mortality and all-cause mortality, the findings are at risk of error due to the small numbers of participants across studies and attrition bias (44). Contradictory conclusions of a recent meta analysis which included long-term follow up data suggest that vitamin D supplementation does not reduce the incidence of cancer or cancer mortality (77).
Vitamin D may also have a protective effect against influenza in infants (78). The Institute of Medicine recommends a Daily Dietary Allowance of vitamin D at 600 IU/day with the Upper Level Intake at 4,000 IU/day for bone health (50). Oral supplementation has been shown to be the safest way to increase vitamin D levels (51), although considerable debate continues on how this may translate to optimizing vitamin D status (45). Therefore, patients should consult with their physicians if a deficiency is suspected to assess the amount of vitamin D needed for health maintenance and to avoid side effects such as kidney stones or high levels of calcium in blood or urine.
The most biologically active metabolite of vitamin D is calcitriol, which regulates calcium and phosphate homeostasis (52). In humans, the primary function of vitamin D is to maintain normal levels of serum calcium and phosphorus concentrations by enhancing small intestine dietary absorption efficiency of these minerals. 25-hydroxyvitamin D [25(OH)D] enhances the efficiency of calcium and phosphorus absorption along the entire small intestine, but primarily in the duodenum and jejunum (5). When dietary calcium intake is insufficient, 25(OH)D and parathyroid hormone (PTH) mobilize monocytic stem cells in the bone marrow to become mature osteoclasts. These osteoclasts mobilize calcium from the bones, thereby maintaining blood calcium levels (50). Vitamin D is thought to have physiological effects in other parts of the body as well because vitamin D receptors (VDRs) are found in the cells of other organs that include intestines, kidney, stomach, brain, prostate, breast, and white blood cells (2) (53).
The anticancer effect of vitamin D is thought to be due to induction of cell differentiation (1) (54) and antiproliferation (55). In lymphoma cells, interventional 25(OH)D3 to normalize levels (>30 ng/mL) resulted in significantly stronger antibody-dependent cell-mediated cytotoxicity, suggesting benefit in D-deficient individuals receiving rituximab (27). In xenograft models of breast cancer, dietary D3 elevated circulating D levels and increased CYP27B1 expression in both tumor and intestines, suggesting it stimulates local calcitriol synthesis in the tumor microenvironment and promotes the ensuing paracrine/autocrine actions that contribute to its anticancer activity (20). The upregulation of CYP27B1 expression by tumors was unique to D3 versus calcitriol in the same tissue (20). In other animal models, a positive feedback signaling loop between the serine-protein kinase ATM (ataxia telangiectasia mutated) and the VDR was identified as critical for cancer chemoprevention by vitamin D (56).
Calcitriol, the hormonally active form of vitamin D3, targets the vitamin D degrading enzyme CYP24A1, which is most abundant in the kidney, but also expressed in several other tissues (57). CYP24A1 overexpression in colon, ovary, breast, lung, and esophageal malignancies, likely leads to degradation of the locally available D3, impairing its antitumorigenic action in the tumor tissue (57).
Individuals with kidney stones, kidney disease, high blood calcium levels, gastrointestinal disease, heart disease, liver disease or other diseases associated with disorders of calcium metabolism should seek medical advice before taking supplemental vitamin D (9).
Life-threatening hypercalcemia: In two women resulting from intake of over-the-counter vitamin-D concentrated supplements that were 100 — 1,000 times higher than stated on the label (58). Hypercalcemic crisis: In a 30-year-old woman after taking large quantities of vitamin D for an unknown period of time (59).
Acute renal failure and hypervitaminosis A: In a 51-year old woman after consuming an over-the-counter vitamin D supplement, which also caused vitamin A toxicity possibly due to renal failure related to the hypercalcemia induced by vitamin D toxicity (60).